Drug intelligence / Profile preview

norfloxacin

Development stage
Phase 4
Lead developer
Kyorin Pharmaceutical
Modality
Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Norfloxacin is a synthetic, broad-spectrum fluoroquinolone antibiotic used primarily to treat bacterial infections of the urinary tract, prostate, and certain sexually transmitted infections such as gonorrhea. It acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV—enzymes essential for DNA replication, transcription, repair, and recombination in bacteria. This inhibition leads to disruption of bacterial cell division and ultimately results in bactericidal activity. Norfloxacin is more selective for bacterial enzymes than mammalian ones and accumulates in the urine, making it especially effective for urinary tract infections. Due to potential serious adverse effects (such as tendinitis or tendon rupture), its use is generally reserved for cases where alternative treatments are not suitable[1][3][4][5][7].

Brand names
Noroxin
Other names
norfloxacin
02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on norfloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norfloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call